newsfilter
← Earnings
Earnings Releases·

Vycor Medical — Three and Nine Months Ended September 30, 2026 Earnings Summary

Vycor Medical, Inc. reported revenue of $414,895 for the three months ended September 30, 2026, representing an 18% decrease compared to the same period in 2025. For the nine-month period, total revenue was $1,291,699, an 11% decline from the prior year, driven primarily by lower sales in the Vycor Medical division which produced the ViewSite Brain Access System. The company recorded a GAAP net loss of $161,447 for the quarter and $325,812 for the nine months, while non-GAAP operating profit improved to $43,011 for the quarter and $125,751 for the nine months. Additionally, four new peer-reviewed studies on the ViewSite system were published during 2026, bringing the total number of clinical papers to 54.